Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Non-Current Assets (2016 - 2026)

Angiodynamics' Non-Current Assets history spans 16 years, with the latest figure at $105.1 million for Q1 2026.

  • For Q1 2026, Non-Current Assets fell 7.08% year-over-year to $105.1 million; the TTM value through Feb 2026 reached $434.3 million, down 8.53%, while the annual FY2025 figure was $111.8 million, 10.13% down from the prior year.
  • Non-Current Assets reached $105.1 million in Q1 2026 per ANGO's latest filing, down from $108.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $415.5 million in Q1 2022 to a low of $105.1 million in Q1 2026.
  • Average Non-Current Assets over 5 years is $238.8 million, with a median of $127.9 million recorded in 2024.
  • Peak YoY movement for Non-Current Assets: fell 2.65% in 2022, then crashed 67.22% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $399.4 million in 2022, then fell by 21.34% to $314.2 million in 2023, then crashed by 63.02% to $116.2 million in 2024, then decreased by 6.76% to $108.3 million in 2025, then dropped by 2.96% to $105.1 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Non-Current Assets are $105.1 million (Q1 2026), $108.3 million (Q4 2025), and $109.0 million (Q3 2025).